Categorised under:
Cardio-thoracic
>
Non-coronary intervention
>
Aortic Valves
(Reuters) - Medtronic\'s CoreValve non-invasive aortic valve replacement system led to significantly fewer deaths than open heart surgery after one year in patients who had previously undergone coronary bypass procedures, according to data from a clinical trial.
Our article examines a number of medical devices currently available on the marketplace, for the procedure.
St. Jude Medical is expanding its European transcatheter aortic valve implantation study to include a larger 25mm valve in the treatment of patients with severe aortic stenosis.
The results showed no apparent difference in patient outcomes except the Medtronic CoreValve was associated with more permanent pacemakers than the Edwards Sapien XT.
High survival rates and improved quality of life are reported in a medical device manufacturer's study findings.
Medtronic has announced the completion of the company's patient enrollment in the extreme risk study in its CoreValve U.S. Trial...
Did you know you can Register for FREE with this website?
Registration gives you full access to all of the features of WhichMedicalDevice. Find out more ...
WhichMedicalDevice is a FREE resource created by clinicians for clinicians.
Registration is free and gives you unlimited access to all of the content and features of this website.
Find out more...Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...
Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.
We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.